These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19010520

  • 1. Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
    Isbarn H, Jeldres C, Budäus L, Salomon G, Schlomm T, Steuber T, Chun FK, Ahyai S, Capitanio U, Haese A, Heinzer H, Huland H, Graefen M, Karakiewicz P.
    Urology; 2009 Mar; 73(3):615-9. PubMed ID: 19010520
    [Abstract] [Full Text] [Related]

  • 2. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
    Freedland SJ, Grubb KA, Yiu SK, Humphreys EB, Nielsen ME, Mangold LA, Isaacs WB, Partin AW.
    J Urol; 2005 Sep; 174(3):919-22. PubMed ID: 16093988
    [Abstract] [Full Text] [Related]

  • 3. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A, Karakiewicz PI, Chun FK, Suardi N, Gallina A, Abdollah F, Freschi M, Doglioni C, Rigatti P, Montorsi F.
    Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
    [Abstract] [Full Text] [Related]

  • 4. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
    Freedland SJ, Grubb KA, Yiu SK, Nielsen ME, Mangold LA, Isaacs WB, Epstein JI, Partin AW.
    J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
    [Abstract] [Full Text] [Related]

  • 5. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
    Chun FK, Briganti A, Antebi E, Graefen M, Currlin E, Steuber T, Schlomm T, Walz J, Haese A, Friedrich MG, Ahyai SA, Eichelberg C, Salomon G, Gallina A, Erbersdobler A, Perrotte P, Heinzer H, Huland H, Karakiewicz PI.
    BJU Int; 2006 Dec; 98(6):1204-9. PubMed ID: 17034506
    [Abstract] [Full Text] [Related]

  • 6. Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?
    Lee SE, Lee WK, Jeong MS, Abdullajanov M, Kim DS, Park HZ, Jeong SJ, Yoon CY, Byun SS, Choe G, Hong SK.
    BJU Int; 2011 Apr; 107(8):1250-5. PubMed ID: 20880194
    [Abstract] [Full Text] [Related]

  • 7. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
    Motamedinia P, Korets R, Spencer BA, Benson MC, McKiernan JM.
    Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
    [Abstract] [Full Text] [Related]

  • 8. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.
    Palisaar RJ, Noldus J, Graefen M, Erbersdobler A, Haese A, Huland H.
    Eur Urol; 2005 Feb; 47(2):176-84. PubMed ID: 15661411
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
    Isbarn H, Ahyai SA, Chun FK, Budäus L, Schlomm T, Salomon G, Zacharias M, Erbersdobler A, Köllermann J, Sauter G, Huland H, Graefen M, Steuber T.
    Eur Urol; 2009 Feb; 55(2):394-401. PubMed ID: 18718699
    [Abstract] [Full Text] [Related]

  • 10. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort.
    Tareen B, Sankin A, Godoy G, Temkin S, Lepor H, Taneja SS.
    Urology; 2009 Feb; 73(2):351-4; discussion 354-5. PubMed ID: 19038430
    [Abstract] [Full Text] [Related]

  • 11. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A, Capitanio U, Chun FK, Gallina A, Suardi N, Salonia A, Da Pozzo LF, Colombo R, Di Girolamo V, Bertini R, Guazzoni G, Karakiewicz PI, Montorsi F, Rigatti P.
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [Abstract] [Full Text] [Related]

  • 12. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ.
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [Abstract] [Full Text] [Related]

  • 13. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
    Tomaszewski JJ, Chen YF, Bertolet M, Ristau BT, Woldemichael E, Nelson JB.
    Urology; 2013 May; 81(5):992-6. PubMed ID: 23453649
    [Abstract] [Full Text] [Related]

  • 14. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    Bañez LL, Sun L, Trock BJ, Han M, Partin AW, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Moul JW, Freedland SJ.
    J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
    [Abstract] [Full Text] [Related]

  • 15. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
    Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA, Catalona WJ.
    J Urol; 2007 Jan; 177(1):102-6; discussion 106. PubMed ID: 17162013
    [Abstract] [Full Text] [Related]

  • 16. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML.
    Cancer; 2006 Aug 01; 107(3):521-9. PubMed ID: 16773619
    [Abstract] [Full Text] [Related]

  • 17. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
    Pfitzenmaier J, Pritsch M, Haferkamp A, Jakobi H, Fritsch F, Gilfrich C, Djakovic N, Buse S, Pahernik S, Hohenfellner M.
    BJU Int; 2009 Apr 01; 103(7):877-82. PubMed ID: 19007372
    [Abstract] [Full Text] [Related]

  • 18. Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
    Gallina A, Karakiewicz PI, Chun FK, Briganti A, Graefen M, Montorsi F, Walz J, Jeldres C, Erbersdobler A, Salonia A, Suardi N, Dehò F, Schlomm T, Scattoni V, Haese A, Heinzer H, Valiquette L, Rigatti P, Huland H.
    BJU Int; 2007 Jun 01; 99(6):1404-8. PubMed ID: 17428250
    [Abstract] [Full Text] [Related]

  • 19. Impact of prostate size and body mass index on perioperative morbidity after laparoscopic radical prostatectomy.
    Singh A, Fagin R, Shah G, Shekarriz B.
    J Urol; 2005 Feb 01; 173(2):552-4. PubMed ID: 15643251
    [Abstract] [Full Text] [Related]

  • 20. Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
    Gallina A, Chun FK, Suardi N, Eastham JA, Perrotte P, Graefen M, Hutterer G, Huland H, Klein EA, Reuther A, Montorsi F, Briganti A, Shariat SF, Roehrborn CG, de la Taille A, Salomon L, Karakiewicz PI.
    BJU Int; 2008 Jun 01; 101(12):1513-8. PubMed ID: 18422773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.